Reports
Sale
Global Human Microbiome Market Size, Share: By Product Type: Probiotics, Prebiotics, Medical Foods, Supplements, Others; By Application: Therapeutics, Diagnostics; By Disease Type: Obesity, Diabetes, Autoimmune Disorder, Other Disease; By Distribution Channel; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Human Microbiome Market Outlook
The global human microbiome market size was valued at USD 591.63 million in 2023, driven by the increasing the rising technical advancements in diagnostic tools across the globe. The market size is anticipated to grow at a CAGR of 23% during the forecast period of 2024-2032 to achieve a value of USD 3,812.38 million by 2032.
Human Microbiome: Introduction
Human microbiome refers to the vast collection of microorganisms that reside in and on the human body, including bacteria, viruses, fungi, and other microbes. The collection of all microorganisms found on or in human tissues and biofluids, along with corresponding anatomical locations, include the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract, among others.
Global Human Microbiome Market Analysis
The study of the human microbiome has gained significant attention in recent years due to its potential impact on human health and disease. The market encompasses various products, services, and research efforts, aimed at understanding and harnessing the potential of the microbiome. The increase in research and development activities that are focused on exploring the role of the human microbiome in various aspects of health, including digestion, immunity, metabolism, and disease development, has been contributing to the human microbiome market growth.
Additionally, microbiome-based therapies are being explored for various conditions, including gastrointestinal disorders, immune-related diseases, and metabolic disorders, owing to the growth of the market. Companies are capitalizing on the growing consumer interest in improving health and well-being through microbiome-focused products. The human microbiome market development is also propelled by the increasing collaborations and partnerships between academic institutions, pharmaceutical companies, biotechnology firms, and diagnostic companies.
Global Human Microbiome Market Segmentations
Market Breakup by Product Type
- Probiotics
- Prebiotics
- Medical Foods
- Supplements
- Others
Market Breakup by Application
- Therapeutics
- Diagnostics
Market Breakup by Disease Type
- Obesity
- Diabetes
- Autoimmune Disorder
- Metabolic and Gastrointestinal Disorders
- Cancer
- Other Disease
Market Breakup by Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Supermarkets and Hypermarkets
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Human Microbiome Market Overview
The market for human microbiome is expanding significantly and is anticipated to continue doing so as a result of growing knowledge of the intricate relationships between the microbiome and human health. Due to the characterization, microbiome functioning has advanced scientific knowledge and allowed for the discovery of novel therapeutic targets, diagnostic indicators, and therapies.
The global human microbiome market expansion is being driven by the rising technical advancements in diagnostic tools and the rising awareness of illness diagnosis. Academic and research organizations, biotechnology and pharmaceutical firms, providers of diagnostic and sequencing equipment, and probiotic and prebiotic producers are some of the major stakeholders in the market for the human microbiome. The increased emphasis on preventative care is anticipated to raise the need for personalized medicines and treatments, along with the diagnostics for infectious diseases, both of which are directly influencing the market growth. These businesses engage in product development, clinical trials, research and development, and commercialization activities. The expanding global market for human microbiomes is also responsible for the rising number of partnerships between academic institutions and biotechnology, pharmaceutical, and other businesses.
Global Human Microbiome Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ENTEROME
- Yakult
- DuPont
- Metabiomics Corporation
- ViThera Pharmaceuticals, Inc.
- Second Genome Inc.
- MICROBIOME THERAPEUTICS LLC
- Vedanta Biosciences, Inc.
- Osel, Inc.
- Merck Sharp & Dohme Corp
- Seres Therapeutics
- Synthetic Biologics, Inc.
- 4D pharma plc
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Disease Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Human Microbiome Market Overview
3.1 Global Human Microbiome Market Historical Value (2017-2023)
3.2 Global Human Microbiome Market Forecast Value (2024-2032)
4 Global Human Microbiome Market Landscape
4.1 Global Human Microbiome Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Human Microbiome Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
4.2.3 Analysis by Disease Type
4.2.4 Analysis by Distribution Channel
5 Global Human Microbiome Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Human Microbiome Market Segmentation
6.1 Global Human Microbiome Market by Product Type
6.1.1 Market Overview
6.1.2 Probiotics
6.1.3 Prebiotics
6.1.4 Medical Foods
6.1.5 Supplements
6.1.6 Others
6.2 Global Human Microbiome Market by Application
6.2.1 Market Overview
6.2.2 Therapeutics
6.2.3 Diagnostics
6.3 Global Human Microbiome Market by Disease Type
6.3.1 Market Overview
6.3.2 Obesity
6.3.3 Diabetes
6.3.4 Autoimmune Disorder
6.3.5 Metabolic and Gastrointestinal Disorders
6.3.6 Cancer
6.3.7 Other Disease
6.4 Global Human Microbiome Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Retail Pharmacies
6.4.3 Online Pharmacies
6.4.4 Supermarkets and Hypermarkets
6.4.5 Others
6.5 Global Human Microbiome Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Human Microbiome Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Human Microbiome Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Human Microbiome Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Human Microbiome Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Human Microbiome Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 ENTEROME
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Yakult
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 DuPont
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Metabiomics Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ViThera Pharmaceuticals, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Second Genome Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 MICROBIOME THERAPEUTICS LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Vedanta Biosciences, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Osel, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Merck Sharp & Dohme Corp
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Seres Therapeutics
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Synthetic Biologics, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 4D pharma plc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Human Microbiome Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 591.63 billion in 2023, driven by the rising prevalence of eye disorders.
The market size is anticipated to grow at a CAGR of 23% during the forecast period of 2024-2032 and reach a market value of USD 3,812.38 billion by 2032.
The rising technical advancements in diagnostic tools and the rising awareness of illness diagnosis are some of the key factors aiding the growth of the market.
The rising exploration of microbiome-based therapies for their treatment potential in various medical conditions, such as gastrointestinal disorders, immune-related diseases, and metabolic disorders, is a key trend propelling the growth of the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is leading the global market.
The different types of products in the market include prebiotics, medical foods, and supplements, among others.
The disease types include obesity, diabetes, cancer, and autoimmune disorder, metabolic and gastrointestinal disorder, among others.
Human microbiome finds wide applications in therapeutics and diagnostics.
The different distribution channels in the market are retail pharmacies, online pharmacies, supermarkets and hypermarkets, among others.
Key players involved in the market are ENTEROME, Yakult, DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Inc., Second Genome Inc., MICROBIOME THERAPEUTICS LLC, Vedanta Biosciences, Inc., Osel, Inc., Merck Sharp & Dohme Corp, Seres Therapeutics, Synthetic Biologics, Inc., and 4D pharma plc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER